<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Dedeilia A</submitter><funding>Dr. Miriam and Sheldon G. Adelson Medical Research Foundation</funding><funding>Harvard Medical School</funding><funding>Harvard Catalyst</funding><funding>Huiying Foundation</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>In the current era of effective adjuvant therapies and de-escalation of surgery, distinguishing which patients with high-risk stage II melanoma are at increased risk of recurrence after excision of the primary lesion is essential to determining appropriate treatment and surveillance plans.&lt;h4>Methods&lt;/h4>A single-center retrospective study analyzed patients with stage IIB or IIC melanoma. Demographic and tumor data were collected, and genomic analysis of formalin-fixed, paraffin-embedded tissue samples was performed via an internal next-generation sequencing (NGS) platform (SNaPshot). The end points examined were relapse-free survival (RFS), distant metastasis-free survival (DMFS), overall survival (OS), and melanoma-specific survival (MSS). Uni- and multivariable Cox re</pubmed_abstract><journal>Annals of surgical oncology</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10908640</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II Melanoma.</pubmed_title><pmcid>PMC10908640</pmcid><funding_grant_id>George</funding_grant_id><funding_grant_id>National Institutes of Health Award KL2 TR002542</funding_grant_id><funding_grant_id>Patricia K. Donahoe Award</funding_grant_id><funding_grant_id>Marie Vergottis Postdoctoral Fellowship</funding_grant_id><pubmed_authors>Dedeilia A</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Boland GM</pubmed_authors><pubmed_authors>Lawless A</pubmed_authors><pubmed_authors>Tunsiricharoengul S</pubmed_authors><pubmed_authors>Lwin T</pubmed_authors><pubmed_authors>Sharova T</pubmed_authors><pubmed_authors>Tarantino G</pubmed_authors><pubmed_authors>Liu D</pubmed_authors><pubmed_authors>Cohen S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II Melanoma.</name><description>&lt;h4>Background&lt;/h4>In the current era of effective adjuvant therapies and de-escalation of surgery, distinguishing which patients with high-risk stage II melanoma are at increased risk of recurrence after excision of the primary lesion is essential to determining appropriate treatment and surveillance plans.&lt;h4>Methods&lt;/h4>A single-center retrospective study analyzed patients with stage IIB or IIC melanoma. Demographic and tumor data were collected, and genomic analysis of formalin-fixed, paraffin-embedded tissue samples was performed via an internal next-generation sequencing (NGS) platform (SNaPshot). The end points examined were relapse-free survival (RFS), distant metastasis-free survival (DMFS), overall survival (OS), and melanoma-specific survival (MSS). Uni- and multivariable Cox re</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Dec</publication><modification>2025-04-18T14:47:58.854Z</modification><creation>2025-04-07T01:06:27.252Z</creation></dates><accession>S-EPMC10908640</accession><cross_references><pubmed>38158497</pubmed><doi>10.1245/s10434-023-14724-5</doi></cross_references></HashMap>